Blinded sample size recalculation in adaptive enrichment designs

Cites Work

Basic concepts of group sequential and adaptive group sequential test procedures
Comparison of design strategies for a three-arm clinical trial with time-to-event endpoint: Power, time-to-analysis, and operational aspects
Internal pilots for observational studies
Adaptive Group Sequential Designs for Clinical Trials: Combining the Advantages of Adaptive and of Classical Group Sequential Approaches
On closed testing procedures with special reference to ordered analysis of variance
Designed Extension of Studies Based on Conditional Power
On the Use of the Upper Confidence Limit for the Variance from a Pilot Sample for Sample Size Determination
Evaluation of Experiments with Adaptive Interim Analyses
Blinded and unblinded sample size reestimation procedures for stepped‐wedge cluster randomized trials
Blinded and unblinded sample size reestimation in crossover trials balanced for period
Methods and Applications of Sample Size Calculation and Recalculation in Clinical Trials
Confirmatory Seamless Phase II/III Clinical Trials with Hypotheses Selection at Interim: General Concepts
Confirmatory Seamless Phase II/III Clinical Trials with Hypotheses Selection at Interim: Applications and Practical Considerations
Adaptive seamless clinical trials using early outcomes for treatment or subgroup selection: Methods, simulation model and their implementation in R
Sample size recalculation in multicenter randomized controlled clinical trials based on noncomparative data
Optimal promising zone designs
A conditional error function approach for adaptive enrichment designs with continuous endpoints
Sample size re-estimation for clinical trials with longitudinal negative binomial counts including time trends
Blinded continuous monitoring of nuisance parameters in clinical trials

This page was built for publication: Blinded sample size recalculation in adaptive enrichment designs